From: Assessment the role of tranexamic acid in prevention of postpartum hemorrhage
RBCV | Study group “TXA” (n=50) | Control group “placebo” (n=50) | P |
---|---|---|---|
Preoperative | |||
Range | 1391–2120 | 1311–2095 | 0.152 |
Mean±SD | 1764.08±189.62 | 1703.48±232.51 | |
Postoperative | |||
Range | 1308–1976 | 1073–1900 | 0.005* |
Mean±SD | 1624.88±184.75 | 1478.40±223.51 | |
Reduction | |||
Mean±SD | 139.20±38.98 | 225.08±63.02 | <0.001** |